No abstract available
MeSH terms
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / adverse effects
-
Clinical Trials as Topic
-
Disease-Free Survival
-
Drug Evaluation* / psychology
-
Drug Evaluation* / trends
-
Hematologic Neoplasms / drug therapy*
-
Hematologic Neoplasms / mortality
-
Hematologic Neoplasms / psychology
-
Humans
-
Patient Participation* / psychology
-
Patient Participation* / trends
-
Quality of Life* / psychology
-
United States
-
United States Food and Drug Administration